GBIO generationbio.com: Market Capitalization to Book Value Ratio

Generation Bio Co. (GBIO) - corporate logo

Generation Bio Co. (GBIO) develops non-viral gene delivery mechanisms for the treatment of muscle and liver pathologies, utilizing RapidSNA to scale drug production. This price chart confirms the asset's dynamics, with a value of 0.72. Generation Bio Co. (GBIO) holds patents for a proprietary DNA synthesis method, earning royalty payments from major pharmaceutical behemoths. The immense potential of ceDNA platforms ensures colossal long-term industry demand.

generationbio.com (GBIO): Capitalization to Book Value Ratio from 07/04/2022 to 02/21/2026

GBIO (Generation Bio Co.): analytical breakdowns and indicator data

- price and consensus price forecast:
Price Chart generationbio.com|GBIO - Average Forecast Price
- market capitalization data:
Market Capitalization Generation Bio Corp|GBIO - Business Value
- book capitalization data:
Net Assets per Single Share Generation Bio|GBIO - Accounting Capitalization|Market Capitalization to Book Value Ratio generationbio.com|GBIO - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Generation Bio Co.|GBIO - Long-Term Indebtedness to Equity|Short-Term Debt to Capital generationbio.com|GBIO - Company Cumulative Debt|Debt to Book Capitalization Ratio Generation Bio Corp
Fundamental valuation:GBIO, Generation Bio Co
Product sample of Generation Bio Co.

This indicator is calculated as the quotient of the total market capitalization divided by the total equity. It reflects the extent to which the market overvalues net assets and the sensitivity of the valuation to shifts in macroeconomic sentiment. For Generation Bio Co. (GBIO), this gap is driven by the high value of its proprietary ctDNA platform and a protected production cycle. The historical P/BV multiple for Generation Bio Co. (GBIO) illustrates the dynamics of this fundamental premium.

Competitor analysis

Market Value to Book Value Ratio TEM|qiagen.com (QGEN) - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Ionis (IONS)|Capitalization to Book Value Ratio RGEN|Market Value to Book Value Ratio Avidity RNA|Capitalization to Book Value Ratio CRISPR (CRSP)|Market Capitalization to Book Value Ratio WGS (GeneDx Holdings Corp.)|Market Capitalization to Book Value Ratio ultragenyx.com RARE|Market Capitalization to Book Value Ratio BEAM|SRPT - Market Value to Equity Ratio|Market Capitalization to Book Value Ratio TWST|TXG (10x) - Market-to-Book Ratio|Market Value to Book Value Ratio Intellia Therapeutics (NTLA)|Capitalization to Book Value Ratio stoketherapeutics.com|BioLife Solutions - Market Capitalization to Book Value Ratio|Market-to-Book Ratio WVE (Wave Life Sciences Ltd)|Market Value to Book Value Ratio Maze Tx|Market Value to Book Value Sionna Corp SION|Prime Medicine, Inc. - Market Capitalization to Book Value Ratio|tayshagtx.com (TSHA) - Market Capitalization to Book Value Ratio|QURE - Market Cap to Net Assets Ratio|MeiraGTx Holdings (MGTX) - Market Cap to Book Value Multiple|RGNX: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value SLDB|Ocugen, Inc. - Market Value to Book Value Ratio|Market-to-Book Ratio PACB (pacb.com)|BNTC - Market Value to Book Value Ratio|DSGN - Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio Rocket Pharmaceuticals Inc (RCKT)|FDMT - Market Value to Book Value|lexeotx.com (LXEO) - Market Capitalization to Book Value Ratio|Korro Bio (KRRO) - Market Value to Book Value Ratio|EDIT: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value SLN|ProQR Therapeutics N.V. - Market Value to Book Value Ratio|Market-to-Book Ratio codexis.com CDXS|Market Cap to Net Assets Ratio Sangamo Therapeutics|Market Value to Book Value Nautilus Biotechnology, Inc. NAUT|MGX: Market Capitalization to Book Value Ratio|DTIL: Market Cap to Net Assets Ratio|Market Value to Book Value Ratio BOLD|Market-to-Book Ratio Exicure|IMNN: Market Cap to Net Assets Ratio|Market Capitalization to Book Value RXi Pharmaceuticals|MBIO: Market Capitalization to Book Value Ratio|Market Value to Equity Ratio transcodetherapeutics.com (RNAZ)|Market Capitalization to Book Value Ratio Bionano Genomics BNGO|Market Value to Book Value Ratio Applied DNA Corp APDN|Market Capitalization to Book Value Ratio BLUE (bluebird bio, Inc.)|IPA: Market Capitalization to Book Value|Market Value to Book Value Ratio OMGA|Singular Genomics Systems, Inc. (OMIC) - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Regulus Therapeutics Inc (RGLS)|Capitalization to Book Value Ratio SYRS|Market Value to Book Value Ratio Telesis Bio, Inc. TBIO|Capitalization to Book Value Ratio traconpharma.com (TCON)|Market Capitalization to Book Value Ratio UBX (Unity Biotechnology, Inc.)